Table 2.
Postoperative and complications data.
| N = 70 | Group 1 Without Omentopexy N (%) |
Group 2 With Omentopexy N (%) |
P- value | |
|---|---|---|---|---|
| Postoperative data | ||||
| Intra-hospital Nausea | 36 (51.4%) | 30 (42.9%) | .084 | |
| Days of Hospital Stay(Mean ± Std) | 4.5 ± 1.2 | 1.8 ± 0.97 | 0.000 | |
| Postoperative antinausea pharmacologic requirement | ||||
| ondansetron | 54 (77.1%) | 8(11.4%) | 0.000 | |
| After Discharge | ||||
| Days till return to work(Mean ± Std) | 14.6 ± 7.7 | 11.3 ± 7.9 | .665 | |
| ≤7 | 12 (17.1%) | 31 (44.3%) | ||
| 8–14 | 46 (65.7%) | 30 (42.9%) | ||
| ≥15 | 12 (17.1%) | 9 (12.9%) | ||
| Nausea | 13 (18.6%) | 8 (11.4%) | 0.344 | |
| Vomiting | 8 (11.4%) | 6 (8.6%) | 0.779 | |
| Regurgitation | 33 (47.1%) | 18 (25.7%) | 0.790 | |
| Morbidity data | ||||
| Intraoperative Complications |
0(0.0%) | 0(0.0%) | 1 | |
| Postoperative complications | ||||
| Bleeding | 1(1.4%) | 0(0.0%) | 1 | |
| Leak | 0(0.0%) | 1(1.4%) | 1 | |